AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
The Importance of Combination Therapies and the Shift Towards Minimal Residual Disease
The chapter discusses the significance of combining therapies in the treatment of myeloma, emphasizing the early introduction of effective therapies and the use of bi-specifics and CAR T cells. It highlights the shift towards using different therapies to achieve deep responses, particularly focusing on minimal residual disease as an endpoint.